Shijiazhuang Yiling Pharmaceutical Co Ltd. Stock Analysis 002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in pharmaceutical manufacturing. The company is headquartered in Shijiazhuang, Hebei and currently employs 11,343 full-time employees. The company went IPO on 2011-07-28. The firm primarily operates three businesses. The patented traditional Chinese medicine business includes compound traditional Chinese medicines, component-based traditional Chinese medicines, single-component traditional Chinese medicines and others. The chemical pharmaceutical business includes chemical drugs such as ordinary oral solid dosage forms, non-cytotoxic oral antitumor solid dosage forms, antitumor drugs, and controlled-release dosage forms. The health industry business includes a series of products that promote blood circulation and mental health, nourish essence, combat aging, and enhance immunity, support physical activity, relieve fatigue, and protect joints, calm the mind, aid sleep, and improve mood, and Lianhua respiratory health products.